Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico

References

• World Health Organization. Influenza (seasonal); 2018 [accessed 2019 March 11]. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).
   Google Scholar
• Ruiz-Matus C, Kuri-Morales P, Narro-Robles J. Behavior of influenza seasons in Mexico from 2010 to 2016: analysis and prospective. Gac Med Mex. 2017;153:205–13.
   PubMed Web of Science ®Google Scholar
• Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–300. doi:10.1016/S0140-6736(17)33293-2.
   PubMed Web of Science ®Google Scholar
• Mexican Secretariat of Health. Influenza Estacional 2015; 2015 [accessed 2019 March 11]. https://www.gob.mx/salud/censia/articulos/influenza-estacional-temporada–2018–2019.
   Google Scholar
• Cortes-Alcala R, Dos Santos G, DeAntonio R, Devadiga R, Ruiz-Matus C, Jimenez-Corona ME, Diaz-Quinonez JA, Romano-Mazzotti L, Cervantes-Apolinar MY, Kuri-Morales P. The burden of influenza A and B in Mexico from the year 2010 to 2013: an observational, retrospective, database study, on records from the directorate general of epidemiology database. Hum Vaccin Immunother. 2018;14(8):1890–98. doi:10.1080/21645515.2018.1456281.
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8(1):81–88. doi:10.4161/hv.8.1.17623.
   PubMed Web of Science ®Google Scholar
• Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, Henriques CM, Njouom R, Fasce RA, Yu H, et al. Epidemiological and virological characteristics of influenza B: results of the global influenza B study. Influenza Other Respir Viruses. 2015;9(Suppl 1):3–12. doi:10.1111/irv.12319.
   PubMedGoogle Scholar
• World Health Organization. Review of global influenza activity, October 2015-October 2016. Wkly Epidemiol Rec. 2016;91(51–52):604–22.
   PubMedGoogle Scholar
• de Boer PT, van Maanen BM, Damm O, Ultsch B, Dolk FCK, Crepey P, Pitman R, Wilschut JC, Postma MJ. A systematic review of the health economic consequences of quadrivalent influenza vaccination. Expert Rev Pharmacoecon Outcomes Res. 2017;17(3):249–65. doi:10.1080/14737167.2017.1343145.
   PubMed Web of Science ®Google Scholar
• Hendriks J, Hutubessy RCW, Grohmann G, Torelli G, Friede M, Kieny MP. Quadrivalent influenza vaccines in low and middle income countries: cost-effectiveness, affordability and availability. Vaccine. 2018;36(28):3993–97. doi:10.1016/j.vaccine.2018.05.099.
   PubMed Web of Science ®Google Scholar
• de Boer PT, Kelso JK, Halder N, Nguyen TP, Moyes J, Cohen C, Barr IG, Postma MJ, Milne GJ. The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia. Vaccine. 2018;36(7):997–1007. doi:10.1016/j.vaccine.2017.12.073.
   PubMed Web of Science ®Google Scholar
• Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine. 2012;30(11):1993–98. doi:10.1016/j.vaccine.2011.12.098.
   PubMed Web of Science ®Google Scholar
• República Mexicana. Consejo Nacional de Población. Población a mitad de año por sexo y edad, 2010–2050; 2017 [accessed 2019 March 11]. https://datos.gob.mx/busca/dataset/proyecciones-de-la-poblacion-de-mexico-y-de-las-entidades-federativas–2016–2050.
   Google Scholar
• Gutiérrez JP, Shamah T, Oropeza C, Hernandez Avila M. Encuesta Nacional de Salud y Nutricion 2012. Cuernavaca (Mexico): Resultados Nacionales. Instituto Nacional de Salud Pública; 2012.
   Google Scholar
• Cruz-Hervert LP, Ferreira-Guerrero E, Díaz-Ortega JL, Trejo-Valdivia B, Téllez-Rojo MM, Mongua-Rodríguez N, Hernández-Serrato MI, Montoya-Rodríguez AA, García-García L. Vaccination coverage in young, middle age, and elderly adults in Mexico. Salud Publica Mex. 2013;55(2):300–06. doi:10.21149/spm.v55s2.5128.
   Google Scholar
• Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States. Hum Vaccin Immunother. 2014;10(5):1171–80. doi:10.4161/hv.28221.
   PubMed Web of Science ®Google Scholar
• Instituto Mexicano del Seguro Social. Acta correspondiente a la celebracion del acto de fallo. Mexico. 2017;2017.
   Google Scholar
• De la Hoz-restrepo F, Castaneda-Orjuela C, Paternina A, Alvis-Guzman N. Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. Vaccine. 2013;31(Suppl 3):C80–7. doi:10.1016/j.vaccine.2013.05.064.
   PubMedGoogle Scholar
• Diaro Oficial de la Federación. Primera seccion. ACUERDO ACDO.AS3.HCT.220217/32.P.DF y sus anexos, dictado por el H. Consejo Técnico, relativo a la aprobación de los Costos Unitarios por Nivel de Atención Médica que regirán para el ejercicio 2017; 2017 [accessed 2019 March 11]. http://dof.gob.mx/nota_detalle.php?codigo=5476988&fecha=21/03/2017.
   Google Scholar
• Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333–40. doi:10.1001/jama.292.11.1333.
   PubMed Web of Science ®Google Scholar
• Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics. 2008;26(11):911–24. doi:10.2165/00019053-200826110-00004.
   PubMed Web of Science ®Google Scholar
• Secretariat of Labor and Social Welfare. Administrative records: salaries; 2017 [accessed 17 Apr 2019]. http://www.stps.gob.mx/gobmx/estadisticas/302_0057.htm?verinfo=2.
   Google Scholar
• The Organisation for Economic Co-operation and Development. OECD data: doctor’s consultations - total per capita, 2011; 2011 [accessed 2019 Jan 16]. https://data.oecd.org/healthcare/doctors-consultations.htm.
   Google Scholar
• Instituto Nacional de Estadistica y Geografia. Censo de Población y Vivienda 2010: tabulados del Cuestionario Básico; table 3.1.3; 2010 [accessed 2019 Jan 16]. http://www.beta.inegi.org.mx/programas/ccpv/2010/.
   Google Scholar
• World Health Organization. FluNet; [accessed 2018 Oct 22]. http://www.who.int/influenza/gisrs_laboratory/flunet/en/.
   Google Scholar
• Fowlkes A, Steffens A, Temte J, Reisdorf E, Rubino H, Martin K, Boxrud D, Wotton J, Brannan L, Ledbetter J, et al. Epidemiologic comparison of laboratory-confirmed influenza virus B Yamagata and Victoria lineage infections during the 2014–2015 influenza season. Open Forum Infect Dis. 2015;2(Suppl 1):1912. doi:10.1093/ofid/ofv133.1459.
   Google Scholar
• US Centers for Disease Control and Prevention. 2011–2012 Influenza Season; 2012 [accessed 2019 Jan 10]. https://www.cdc.gov/flu/pastseasons/1112season.htm.
   Google Scholar
• Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010;(2):CD004876.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2010;(7):CD001269.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012;(8):CD004879.
   PubMed Web of Science ®Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–96. doi:10.1016/j.vaccine.2007.03.046.
   PubMed Web of Science ®Google Scholar
• Gutiérrez JP, Bertozzi SM. Influenza vaccination in the elderly population in Mexico: economic considerations. Salud Publica Mex. 2005;47(3):234–39. doi:10.1590/S0036-36342005000300007.
   PubMed Web of Science ®Google Scholar
• US Internal Revenue Service. Yearly average currency exchange rates; 2019 [accessed 2019 Apr 18]. https://www.irs.gov/individuals/international-taxpayers/yearly-average-currency-exchange-rates.
   Google Scholar
• Jamotte A, Clay E, Macabeo B, Caicedo A, Lopez JG, Bricks L, Romero Prada M, Marrugo R, Alfonso P, Moreno Arevalo B, et al. Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America. Hum Vaccin Immunother. 2017;13(4):877–88. doi:10.1080/21645515.2016.1256928.
   PubMed Web of Science ®Google Scholar
• Quinn E, Jit M, Newall AT. Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination. Expert Rev Pharmacoecon Outcomes Res. 2014;14(3):425–35. doi:10.1586/14737167.2014.908713.
   PubMed Web of Science ®Google Scholar
• Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. Am J Public Health. 2013;103(3):e43–51. doi:10.2105/AJPH.2012.301137.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season. Wkly Epidemiol Rec. 2015;90(11):97–108.
   PubMedGoogle Scholar
• World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season. Wkly Epidemiol Rec. 2012;87(10):83–95.
   PubMedGoogle Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36–44. doi:10.1016/S1473-3099(11)70295-X.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 56th world health assembly: prevention and control of influenza pandemics and annual epidemics. WHA56.19. Geneva (Switzerland): World Health Assembly; 2003.
   Google Scholar